As its first identified member, Interleukin-12 (IL-12) named a whole family of cytokines. In
response to pathogens, the heterodimeric protein, consisting of the two subunits p35 and …

Type 2 diabetes mellitus (T2DM) is a complex disease caused by the interaction between
genetic and environmental factors. A growing number of evidence suggests that the …

The concept of precision medicine is becoming increasingly popular. The use of big data,
genomics and other “omics” like metabolomics, proteomics and transcriptomics could make …

Non-communicable diseases (NCDs) are the leading cause of death and disease burden
globally, cardiovascular diseases (CVDs) account for the major part of death related to …

The global incidence of metabolic disorders like type 2 diabetes mellitus (DM2) has
assumed epidemic proportions, leading to adverse health and socio-economic impacts. It is …

Type 2 diabetes prevalence is still on the rise worldwide. Antidiabetic drugs are widely
prescribed to patients with Type 2 diabetes. Most patients start with metformin which is …

Cardiovascular disorders (CVDs) are a major global health concern, but their underlying
molecular mechanisms are not fully understood. Recent research highlights the role of long …

Personalised therapeutic drugs are the future of the medical drug sector. For manufacturers,
this will require the flexibility to produce many different unique batches within a given facility …

The conception that several infectious diseases were linked to an inherited disorder has
been discussed, and every day, substantial evidence now is supported by the human …

The effectiveness and side effects of Type 2 diabetes (T2D) medication are related to
individual genetic background. SNPs CYP3A4 and CYP2C19 were introduced to machine …